Physician profile
Ellen E Gallagher
NPI 1255377461
$1,692.67
in general payments reported to CMS, 2019-2025
16 companies · $79.68 in 2025
The $79.68 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $901 · 2023: $161 · 2024: $180 · 2025: $79.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $522.64 | 2021-2023 | |
| Boston Scientific Corporation | $444.07 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Novo Nordisk INC | $129.05 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $124.77 | 2021-2022 | |
| Myovant Sciences INC. | $115.54 | 2022 | |
| Exeltis, USA INC. | $85.06 | 2021-2022 | |
| Coopersurgical, INC. | $55.56 | 2022-2023 | Paragard T 380a |
| Astellas Pharma US INC | $47.60 | 2021-2022 | |
| Organon LLC | $30.18 | 2022 | |
| Hologic Sales and Service, LLC | $22.90 | 2022 | |
| Pfizer INC. | $22.00 | 2021 | |
| Sumitomo Pharma America, INC. | $21.72 | 2023 | Myfembree |
| Ethicon US, LLC | $21.62 | 2022 | |
| Seqirus USA INC | $19.33 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.45 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.